Welcome, Guest |
TOPIC:
Dr Freeman in The Pharmaceutical Journel 8 years 1 week ago #15045
| www.pharmaceutical-journal.com/news-and-...s-c/20201038.article Hope the Gilead executive team have a subscription to this delivered to their fancy offices in the Ivory tower's. SVR 24 The following user(s) said Thank You: coral, pat1, mgalbrai, jimmy42, Gaj, Lynne-Francis-facebook, beaches, IRMA88, Hazel, Tommy, Greedfighter, Matt-Kenney-google, fretboard |
Dr Freeman in The Pharmaceutical Journel 8 years 1 week ago #15049
From that article: "Researchers in Australia, where patients can legally import a three-month supply of treatment, studied the efficacy of imported generic antivirals in 419 patients with hepatitis C infection. Their interim results show that the virus was undetectable in 98% of patients at the end of treatment, and in 96% of patients four weeks after stopping treatment". Sounds like 402 soles are on their way to being cured. Gilead's profits are only money; 400 hundred lives are priceless. J. GT3a 1990 Failed Inter 1998, comb in 2000. HCC 2012 Started 24/52 Sof/Dac 27th October 2015. 1. Bloods 2 October 2015: AST - 165 (20-40), ALT - 265 (5-40), GGT 189 (5-50) 2, Bloods 20 November 2015: ALT etc normal; VL 19 3. Bloods 8 January 2016: AST - 40, ALT - 59, GGT 48 VL RNA UND 4. EOT 12 April 2016 - blood tests: all is well, CT scan: okay 5. AFP 11 June 2016: 4 ref< 11 6. VL July 2016: DET 7. Oct16 start treat - June17 UND 8. Jun 18, lfts okay, platelets a bit low. | |
Dr Freeman in The Pharmaceutical Journel 8 years 6 days ago #15157
Great to see him published like this eh, my data is in there somewhere, hope I make it to SVR12, couple of weeks to go yet, feeling good though, good luck to all jim TLDR | |
Time to create page: 0.100 seconds